Showing 461 - 480 results of 646 for search '"metabolic syndrome"', query time: 0.09s Refine Results
  1. 461

    Role of Adipokines and Other Inflammatory Mediators in Gestational Diabetes Mellitus and Previous Gestational Diabetes Mellitus by Nikolaos Vrachnis, Panagiotis Belitsos, Stavros Sifakis, Konstantinos Dafopoulos, Charalambos Siristatidis, Kalliopi I. Pappa, Zoe Iliodromiti

    Published 2012-01-01
    “…Previous Gestational Diabetes Mellitus (pGDM) is a common condition and has been associated with future development of Type 2 Diabetes Mellitus (T2DM) and Metabolic Syndrome (MS) in women affected. The pathogenesis and risk factors implicated in the development of these conditions later in the lives of women with pGDM are not as yet fully understood. …”
    Get full text
    Article
  2. 462

    Central Hypogonadotropic Hypogonadism: Genetic Complexity of a Complex Disease by Marco Marino, Valeria Moriondo, Eleonora Vighi, Elisa Pignatti, Manuela Simoni

    Published 2014-01-01
    “…Central hypogonadotropic hypogonadism (CHH) is an emerging pathological condition frequently associated with overweight, metabolic syndrome, diabetes, and midline defects. The genetic mechanisms involve mutations in at least twenty-four genes regulating GnRH neuronal migration, secretion, and activity. …”
    Get full text
    Article
  3. 463

    Combination Olanzapine and Samidorphan for the Management of Schizophrenia and Bipolar 1 Disorder in Adults: A Narrative Review by Hannah W. Haddad, Elena Boardman, Brooke Williams, Rama Mouhaffel, Adam M. Kaye, Alan D. Kaye

    Published 2022-04-01
    “…However, compared to other AAPs, olanzapine is associated with a greater chance of metabolic syndrome, limiting its clinical use and affecting treatment compliance. …”
    Get full text
    Article
  4. 464

    Obesity and Sleep-Related Breathing Disorders in Middle East and UAE by Mayank G. Vats, Bassam H. Mahboub, Hassan Al Hariri, Ashraf Al Zaabi, Deepa Vats

    Published 2016-01-01
    “…Apart from direct medical, psychological, and quality of life related adverse effects of obesity, many indirect medical comorbidities, namely, obstructive sleep apnea (OSA), obesity hypoventilation syndrome (OHS), diabetes mellitus (DM), hypertension (HTN), and metabolic syndrome, imposes a significant health burden on the individual and community with consequent morbidity and mortality. …”
    Get full text
    Article
  5. 465

    Physical Activity Protects the Human Brain against Metabolic Stress Induced by a Postprandial and Chronic Inflammation by Leo Pruimboom, Charles L. Raison, Frits A. J. Muskiet

    Published 2015-01-01
    “…In recent years, it has become clear that chronic systemic low-grade inflammation is at the root of many, if not all, typically Western diseases associated with the metabolic syndrome. While much focus has been given to sedentary lifestyle as a cause of chronic inflammation, it is less often appreciated that chronic inflammation may also promote a sedentary lifestyle, which in turn causes chronic inflammation. …”
    Get full text
    Article
  6. 466

    Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease by Myrsini Orfanidou, Stergios A. Polyzos

    Published 2024-12-01
    “…Characterized by excessive fat accumulation in the hepatocytes, MASLD is frequently linked to metabolic syndrome components, such as obesity, insulin resistance, dyslipidemia, and hypertension. …”
    Get full text
    Article
  7. 467

    PPARs, Cardiovascular Metabolism, and Function: Near- or Far-from-Equilibrium Pathways by Yves Lecarpentier, Victor Claes, Jean-Louis Hébert

    Published 2010-01-01
    “…Dysfunction of clock genes and PPARγ may lead to hyperphagia, obesity, metabolic syndrome, myocardial infarction and sudden cardiac death, In pathological conditions, regulatory processes of the cardiovascular system may bifurcate towards new states, such as those encountered in hypertension, type 2 diabetes, and heart failure. …”
    Get full text
    Article
  8. 468

    Screening of Aqueous Extract of Persea americana Seeds for Alpha-Glucosidase Inhibitors by Tajudeen Afolayan Lawal

    Published 2022-01-01
    “…If not properly controlled, postprandial hyperglycaemia might progress to diabetes mellitus, a metabolic syndrome. Diabetes is associated with many complications such as retinopathy, heart attack, nephropathy, neuropathy, stroke, and lower limb amputation. …”
    Get full text
    Article
  9. 469

    Fetal Growth Restriction Prediction: How to Move beyond by Debora F. B. Leite, Jose G. Cecatti

    Published 2019-01-01
    “…Growing body of evidence shows their higher risk of adverse outcomes at any period of life, including increased rates of neurologic delay, noncommunicable chronic diseases (central obesity and metabolic syndrome), and mortality. Although there is no consensus regarding its definition, birthweight centile threshold, or follow-up, we believe birthweight <10th centile is the most suitable cutoff for clinical and epidemiological purposes. …”
    Get full text
    Article
  10. 470

    Metabolic health and global cardiovascular risk in obese patients. Endocrinology Service. Cienfuegos, 2021-2022 by Leonelsy Núñez García, Elodia María Rivas Alpízar

    Published 2024-03-01
    “…<p><strong>Foundation:</strong> The overweight and obesity increasing prevalence, two important components of metabolic syndrome, represents a serious health risk.<br /><strong>Objectives:</strong> relate the factors associated with metabolically healthy and unhealthy obese people and estimate the global cardiovascular risk in both groups.…”
    Get full text
    Article
  11. 471

    Metabolic Risk Susceptibility in Men Is Partially Related to Adiponectin/Leptin Ratio by Gloria Lena Vega, Scott M. Grundy

    Published 2013-01-01
    “…But the ratio of adiponectin/leptin decreased progressively with the increase in the number of risk factors for metabolic syndrome. Conclusion. Adipokine levels may reflect adipose tissue triglyceride storage capacity and insulin sensitivity. …”
    Get full text
    Article
  12. 472

    Elevated Adiponectin Serum Levels in Women with Systemic Autoimmune Diseases by Éric Toussirot, Béatrice Gaugler, Malika Bouhaddi, Nhu Uyen Nguyen, Philippe Saas, Gilles Dumoulin

    Published 2010-01-01
    “…However, the precise consequences of these elevated serum adiponectin levels on the metabolic syndrome development and atherosclerotic cardiovascular risk in this patient population still needs to be determined.…”
    Get full text
    Article
  13. 473

    The Decreased Growth Hormone Response to Growth Hormone Releasing Hormone in Obesity Is Associated to Cardiometabolic Risk Factors by Fernando Cordido, Jesús Garcia-Buela, Susana Sangiao-Alvarellos, Teresa Martinez, Ovidio Vidal

    Published 2010-01-01
    “…These data strongly suggest a role for insulin resistance in the decreased GH secretion of obesity and that the blunted GH secretion of central obesity could be the pituitary expression of the metabolic syndrome.…”
    Get full text
    Article
  14. 474

    Comparative Evaluation of Whole Body and Hepatic Insulin Resistance Using Indices from Oral Glucose Tolerance Test in Morbidly Obese Subjects with Nonalcoholic Fatty Liver Disease by Kamran Qureshi, Ronald H. Clements, Fahad Saeed, Gary A. Abrams

    Published 2010-01-01
    “…Nonalcoholic Fatty Liver Disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is a marker of Insulin Resistance (IR). …”
    Get full text
    Article
  15. 475

    High Prevalence of Cardiovascular Disease in End-Stage Kidney Disease Patients Ongoing Hemodialysis in Peru: Why Should We Care About It? by Katia Bravo-Jaimes, Alvaro Whittembury, Vilma Santivañez

    Published 2015-01-01
    “…It was significantly associated with age older than 50 years, metabolic syndrome, C-reactive protein levels, effective blood flow ≤ 300 mL/min, severe anemia, and absence of mild anemia. …”
    Get full text
    Article
  16. 476

    Incidence of Prediabetes and Type 2 Diabetes among People Aged over 20 Years in Ahvaz: A 5-Year Perspective Study (2009–2014) by Seyed Mahmoud Latifi, Majid Karandish, Hajieh Shahbazian, Leila Hardani Pasand

    Published 2016-01-01
    “…The individuals aged over twenty years who had participated in a study on the prevalence of metabolic syndrome in 2009 (Phase 1) in Ahvaz were invited again in 2014. …”
    Get full text
    Article
  17. 477

    Association between Sleep Habits and Metabolically Healthy Obesity in Adults: A Cross-Sectional Study by Thirumagal Kanagasabai, Ramandeep Dhanoa, Jennifer L. Kuk, Chris I. Ardern

    Published 2017-01-01
    “…The absence of metabolic syndrome was used to define MHO. Those with MHO tended to be younger, female, Non-Hispanic Black, never smokers, more physically active, and with less physician diagnosed sleep disorders than MAO. …”
    Get full text
    Article
  18. 478

    Association of Alanine Aminotransferase and Periodontitis: A Cross-Sectional Analysis—NHANES 2009–2012 by R. Constance Wiener, Usha Sambamoorthi, Richard J. Jurevic

    Published 2016-01-01
    “…Alanine Aminotransferase is an enzyme associated with not only liver diseases, liver conditions, and metabolic syndrome, but also inflammation. Periodontitis is associated with increased cytokines and other markers of inflammation. …”
    Get full text
    Article
  19. 479

    Multi-metabolic altered patterns and cardiovascular risk factors associated to hypertension in the community. by Alexis Ocampo Segura., Yoel Alberto Hernández Rodríguez., Benigno Figueiras Ramos., Raúl López Fernández, Mikhail Benet Rodríguez

    Published 2004-04-01
    “…<strong>Fundaments: </strong>Among other factors, hypertension , hypercholesterolemia and hyperinsulonemia form the so called metabolic syndrome Many studies relate hypertension to other risk factors and to metabolic-endocrine disorders. …”
    Get full text
    Article
  20. 480

    Acylcarnitine Profiles in Plasma and Tissues of Hyperglycemic NZO Mice Correlate with Metabolite Changes of Human Diabetes by Anna Weiser, Pieter Giesbertz, Hannelore Daniel, Britta Spanier

    Published 2018-01-01
    “…The New Zealand obese (NZO) mouse is a polygenic model for obesity and diabetes with obese females and obese, diabetes-prone males, used to study traits of the metabolic syndrome like type 2 diabetes mellitus (T2DM), obesity, and dyslipidaemia. …”
    Get full text
    Article